• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • English
    Chinese
    French
    Hindi

    Personalized Medicine Market

    ID: 2161
    128 Pages
    Research Team
    07/2025

    Personalized Medicine Market Research Report Information By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, and Personalized Nutrition and Wellness), By Application (Oncology, CNS, Immunology, Respiratory, and Others), By End-User (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others), and By Region (North Ameri...

    Share:
    ReportInfographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Summary

    Personalized Medicine Market Overview

    The Personalized Medicine Market Size was valued at USD 556.6 Billion in 2023 and is projected to grow from USD 596.7 Billion in 2024 to USD 970.7 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.27% during the forecast period (2024 - 2032).

    The various partnerships between researchers and industry participants, the increasing demand for breakthrough medication discoveries to address the rising incidence of malignancies and other disorders, are the key market drivers enhancing the market growth.

    Personalized Medicine Market Trends

    The development of efficient and advanced technology is driving the market growth

    The primary growth drivers of the global market for customized medicine are the development of efficient and cutting-edge technology, increased public awareness of personalized medicine, an increase in global government initiatives, and the expansion of the production of genetic databases. Additionally, the usage of customized medications is expanding in developing nations particularly in the disciplines of psychiatry, neurology, pulmonary medicine, and antiviral drugs.

    On the other hand, the worldwide market for personalized medicine is being constrained by increased costs for research and development as well as a higher likelihood of negative effects.

    Personalized Medicine Market

    Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

    The demand for rapid onset action treatment procedures, the use of combined drug therapies, the aging of the global population, and the expansion of personalized medicine clinical trials in neurology departments will all contribute to the market growth of the personalized medicine. Additionally, there will be an increase in the number of patients with chronic illnesses like diabetes and cancer.

    The rising prevalence of various cancer types, the low cost of personalized medicine therapy in cancer pharmaceuticals, and a number of other sickness indicators are expected to drive growth in the global market for personalized medicine. According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, with an estimated 10.1 million deaths in 2023. This indicates that around 1 in 6 deaths globally are due to cancer, continuing the trend from previous years.

    The market for personalized medicine is anticipated to expand as a result of recent developments in pharmacogenomics, an increase in the adoption of advanced healthcare facilities, an increase in the costs of creating advanced infrastructures, the advantages and effectiveness of using personalized medicines, and research institutes' development of efficacy and quality of personalized drugs. Thus, driving the Personalized Medicine market revenue.

    Personalized Medicine Market Segment Insights

    Personalized Medicine Product Insights

    The Market segments of Personalized Medicine, based on product includes personalized medicine diagnostics, personalized medicine therapeutics, personalized medical care, and personalized nutrition and wellness. In 2022, personalized nutrition and wellness accounted for the highest percentage. The vast consumption rate and market penetration are to blame for the segment's rise.

    A further factor driving demand is the high percentage of nutrition items sold over-the-counter (OTC), which has less regulatory ramifications. For instance, the American Heart Association reports that nutritionists are pursuing precision nutrition to treat cardiovascular disorders based on individuals' individual sensitivities to particular foods and nutrients.

    Personalized Medicine Application Insights

    The Personalized Medicine Market segmentation, based on Application, includes oncology, CNS, immunology, respiratory, and others. The global market was dominated by the oncology segment in 2022, and it is predicted that this trend will continue throughout the forecast period due to the rising need for tailored medications for the treatment of cancer.

    Additionally, customized medicine enables accurate molecular cancer detection, assisting medical professionals in determining the precise genetic abnormalities or other cancer-causing biomarkers. This accelerates the market growth for individualized medicine.

    Personalized Medicine End-User Insights

    The Market segmentation of Personalized Medicine, based on end-user, includes hospitals, diagnostic centers, research & academic institutes, and others. Due to the specialized facilities provided by hospitals for individualized treatments and solutions for various ailments, the hospitals sector led the market in terms of revenue in 2022.

    However, due to increased investment by pharma and biotech companies in personalized medicine fields and a wide product offering by diagnostic tool companies in personalized medicines, the others segment is anticipated to grow at the fastest rate during the personalized medicine market forecast.

    Figure 1: Personalized Medicine Market, by End Use, 2022 & 2032 (USD Billion)

    Personalized Medicine Market, by End Use, 2022 & 2032 (USD Billion)

    Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

    Personalized Medicine Regional Insights

    By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. In 2022, North America held the largest share—more than 45.80%. This is linked to funding from large pharmaceutical companies and research organizations. All types of ailments are now best treated with personalized medicine, which is why drug discovery and research into any condition now include it.

    In the region, personalized medicine is advancing for diagnostic purposes. For instance, in January 2021 Illumina, Inc. creates the TruSight Oncology 500 (TSO 500) assay, which can identify up to 523 cancer biomarkers using nucleic acids from tumor cells. Further, the U.S. market of Personalized Medicine held the largest market share, and the Canada market of Personalized Medicine was the fastest growing market in the North America region.

    Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2: Personalized Medicine Market SHARE BY REGION 2022 (%)

    Personalized Medicine Market SHARE BY REGION 2022 (%)

    Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

    Europe Personalized Medicine market accounts for the second-largest market share. The primary reason driving the growth of the customized medicine market in this region is the presence of a number of significant players, including Abbott, Qiagen, GE Healthcare, and BASF SE. Additionally, there is a growing need for personalized medicine solutions that can offer more precise and efficient treatments due to the high prevalence of chronic diseases in Europe, including diabetes, cardiovascular disease, and cancer.

    Further, the German market of Personalized Medicine held the largest market share, and the UK market of Personalized Medicine was the fastest growing market in the European region.

    The Asia-Pacific Personalized Medicine market is expected to grow at the fastest CAGR from 2024 to 2032, due to rising demand for personalized diagnostics and novel treatment medications to combat the region's rising disease prevalence. Further, China’s market of Personalized Medicine held the largest market share, and the Indian market of Personalized Medicine was the fastest growing market in the Asia-Pacific region.

    Personalized Medicine Key Market Players & Competitive Insights

    Leading market players are investing heavily in research and development in order to expand their Product lines, which will help the market of Personalized Medicine, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations.

    To expand and survive in a more competitive and rising market climate, Personalized Medicine Industry must offer cost-effective items. Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Personalized Medicine Industry to benefit clients and increase the market sector. In recent years, the Personalized Medicine Industry has offered some of the most significant advantages to medicine.

    Major players in the Personalized Medicine market, including Illumina Inc., Precision Biologics, Danaher Corporation, GE Healthcare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., and Biogen, are attempting to increase market demand by investing in research and development operations.

    Illumina Inc. (Illumina) offers genomic sequencing and array-based technologies for genetic analysis in the fields of cancer, consumer and translational genomics, and molecular diagnostics. The product line of the business includes sequencing kits and reagents, tools and systems for sequencing, kits and reagents for microarrays, reagents for molecular biology, and arrays and reagents. In the Americas, Asia-Pacific, Europe, the Middle East, and Africa, the corporation sells its goods directly to customers as well as through distributors. The U.S. city of San Diego serves as Illumina's corporate headquarters. Illumina, Inc. and the Belgian Society of Medical Oncology signed a study agreement in February 2021 to look into Comprehensive Genomic Profiling in patients with advanced metastatic cancer.

    Nutraceutical goods, nutritional supplements, and medicinal food are all provided by Metagenics Inc. (Metagenics), a corporation that specializes in nutrigenomics. The business provides goods for immune health, men's and women's health, neurological health, blood sugar regulation, metabolic detoxification, stress reduction, and muscle, bone, and joint health in addition to cardiometabolic health. The company also sells products related to general wellness, body composition, and sports nutrition. A manufacturing facility for the business is located in Gig Harbor, Washington.

    In North America, Europe, and Asia-Pacific, Metagenics offers its products through distributors and direct sales. The business's main office is in Aliso Viejo, California, in the United States. The Personalized Lifestyle Medicine Center, a patient clinic and clinical research facility, opened in Washington in January 2019, according to a statement from Metagenics, Inc.

    Key Companies in the market of Personalized Medicine include

      • Precision Biologics
      • Danaher Corporation
      • Celera Diagnostics LLC
      • Decode Genetics Inc.
      • Exact Sciences Corporation
      • IBM Corporation
      • Exagen Inc.
      • Biogen

    Personalized Medicine Application Developments

    January 2022- Through the integration of Viocare's nutrition assessment software with personalized nutrition supplementation to create an end-to-end service platform, Panaceutics Nutrition and Viocare announced a collaborative agreement to produce personalized nutrition for healthcare providers and their subjects using a high-end technology interface.

    December 2021- Roche announced the release of the AVENIO Edge System, which will enhance sequencing technologies by delivering a fully automated, integrated sequencing solution and advancing its precision medicine solutions. The system is constructed with best-in-class core capabilities.

    Personalized Medicine Market Segmentation

    Personalized Medicine Product Outlook

      • Personalized Medicine Diagnostics
      • Personalized Medicine Therapeutics
      • Personalized Medical Care
      • Personalized Nutrition and Wellness

    Personalized Medicine Application Outlook

      • Oncology
      • CNS
      • Immunology
      • Respiratory
      • Others

    Personalized Medicine End-User Outlook

      • Hospitals
      • Diagnostic Centers
      • Research & Academic Institutes
      • Others

    Personalized Medicine Regional Outlook

    • North America
        • US
        • Canada
    • Europe
        • Germany
        • France
        • UK
        • Italy
        • Spain
        • Rest of Europe
    • Asia-Pacific
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • Australia
        • Rest of Asia-Pacific
      • Rest of the World
        • Middle East
      • Africa
      • Latin America

    Market Size & Forecast

    Attribute/Metric Details
    Market Size 2023 USD 556.6 Billion
    Market Size 2024 USD 596.7 Billion
    Market Size 2032 USD 970.7 Billion
    Compound Annual Growth Rate (CAGR) 6.27% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2018- 2021
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Application, End-User, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The U.S., Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Illumina Inc., Precision Biologics, Danaher Corporation, GE Healthcare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., and Biogen
    Key Market Opportunities Technological advancements in diagnostics sector
    Key Market Dynamics The growing demand for novel drug discovery to combat the growing incidence of cancers and other diseases and numerous collaborations among researchers and market players

    Major Players

    Personalized Medicine Market Segmentation

    Personalized Medicine Product Outlook (USD Billion, 2018-2032)

    • Personalized Medicine Diagnostics

    • Personalized Medicine Therapeutics

    • Personalized Medical Care

    • Personalized Nutrition and Wellness

    Personalized Medicine Application Outlook (USD Billion, 2018-2032)

    • Oncology

    • CNS

    • Immunology

    • Respiratory

    • Others

    Personalized Medicine End-User Outlook (USD Billion, 2018-2032)

    • Hospitals

    • Diagnostic Centers

    • Research & Academic Institutes

    • Others

    Personalized Medicine Regional Outlook (USD Billion, 2018-2032)

    • North America Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • US Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Canada Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

    • Europe Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Germany Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • France Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • UK Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Italy Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Spain Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Rest Of Europe Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

    • Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • China Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Japan Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • India Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Australia Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

    • Rest of the World Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Middle East Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Africa Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

      • Latin America Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product

        • Personalized Medicine Diagnostics

        • Personalized Medicine Therapeutics

        • Personalized Medical Care

        • Personalized Nutrition and Wellness

      • Personalized Medicine by Application

        • Oncology

        • CNS

        • Immunology

        • Respiratory

        • Others

      • Personalized Medicine by End-User

        • Hospitals

        • Diagnostic Centers

        • Research & Academic Institutes

        • Others

     

    Market Trends

    Personalized Medicine Market Overview

    The Personalized Medicine Market Size was valued at USD 556.6 Billion in 2023 and is projected to grow from USD 596.7 Billion in 2024 to USD 970.7 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.27% during the forecast period (2024 - 2032).

    The various partnerships between researchers and industry participants, the increasing demand for breakthrough medication discoveries to address the rising incidence of malignancies and other disorders, are the key market drivers enhancing the market growth.

    Personalized Medicine Market Trends

    The development of efficient and advanced technology is driving the market growth

    The primary growth drivers of the global market for customized medicine are the development of efficient and cutting-edge technology, increased public awareness of personalized medicine, an increase in global government initiatives, and the expansion of the production of genetic databases. Additionally, the usage of customized medications is expanding in developing nations particularly in the disciplines of psychiatry, neurology, pulmonary medicine, and antiviral drugs.

    On the other hand, the worldwide market for personalized medicine is being constrained by increased costs for research and development as well as a higher likelihood of negative effects.

    Market Segment Insights

    Smartphone Sensors Smartphone Type Insights

    The Smartphone Sensors market segmentation, based on smartphone type, includes standard smartphone, rugged smartphone, smartwatches, and other wearable. The standard smartphone segment dominated the market, accounting for the maximum market revenue. A smartphone is a mobile phone with a built-in computer and advanced features, such as web browsing and operating system, which are not associated with its counterpart. The rising mobile internet use, rising disposable income in developing countries, and high ownership of premium design smartphones are a few factors that are anticipated to grow smartphone sales. Smartphones are helped by a mobile operating system that offers advanced computing facilities. A smartphone can also work as a digital media player for uploading photos, videos, and music through a single interface.

    Smartphone Sensors Market, By Device Type Outlook, 2024 & 2035

    Smartphone Sensors Manufacturer Insights

    The Smartphone Sensors market segmentation, based on the manufacturer, includes Apple Inc., Samsung Electronics, Huawei Technology, Xiaomi Inc., Oppo, Sony Corporation, HMD Global, and others. The Apple Inc. segment generated the most revenue due to its superior quality. Apple’s iPhone stands out over all other smartphones in the market. Apple Inc. is the market leader because they use more sensors in their devices to provide unique features. For Instance: Apple’s iPhone 12 uses a lidar for depth sensing, proximity for 3D touch, a gyroscope for compass, GPS, face ID for biometrics, auto-off, a barometer, a magnetometer for compass & GPS, and an ambient light sensor for auto-dimming displays. The better user experience, increased accessibility, and more security these sensors offer consumers to boost the segment‘s growth.

    Smartphone Sensors Application Insights

    The Smartphone Sensors market segmentation, based on the manufacturer, includes Apple Inc., Samsung Electronics, Huawei Technology, Xiaomi Inc., Oppo, Sony Corporation, HMD Global, and others. The Apple Inc. segment generated the most revenue due to its superior quality. Apple’s iPhone stands out over all other smartphones in the market. Apple Inc. is the market leader because they use more sensors in their devices to provide unique features. For Instance: Apple’s iPhone 12 uses a lidar for depth sensing, proximity for 3D touch, a gyroscope for compass, GPS, face ID for biometrics, auto-off, a barometer, a magnetometer for compass & GPS, and an ambient light sensor for auto-dimming displays. The better user experience, increased accessibility, and more security these sensors offer consumers to boost the segment‘s growth.

    Smartphone Sensors Regional Insights

    The Smartphone Sensors market segmentation, based on the manufacturer, includes Apple Inc., Samsung Electronics, Huawei Technology, Xiaomi Inc., Oppo, Sony Corporation, HMD Global, and others. The Apple Inc. segment generated the most revenue due to its superior quality. Apple’s iPhone stands out over all other smartphones in the market. Apple Inc. is the market leader because they use more sensors in their devices to provide unique features. For Instance: Apple’s iPhone 12 uses a lidar for depth sensing, proximity for 3D touch, a gyroscope for compass, GPS, face ID for biometrics, auto-off, a barometer, a magnetometer for compass & GPS, and an ambient light sensor for auto-dimming displays. The better user experience, increased accessibility, and more security these sensors offer consumers to boost the segment‘s growth.

    Smartphone Sensors Market, By Device Type Outlook, 2024 & 2035

    Smartphone Sensors Price Insights

    The Smartphone Sensors market segmentation, based on price, includes USD 300 to USD 500, USD 100 to USD 300, above USD 500, and under USD 100. The USD 300 to USD 500 segment dominated the market revenue in the projected period. Most smartphones sold in medium-end devices have a sensor within this range. For instance: Nubia launched a new flagship Android device powered by the latest Snapdragon 8Gen 2CPU. The OEM has also specified that this gadget, which peculiarly seems to go by the name Z50 even though its processor was the z40 Pro, will compete with the Xiaomi 13 and iQOO11 series with cutting-edge LPDDR5X RAM and storage with the most recent UFS 4.0 spec.

    Get more detailed insights about Personalized Medicine Market

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development to expand their product lines, which will help the Smartphone Sensors market, grow even more. Market participants are also undertaking various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and growing market climate, the Smartphone Sensors industry must offer cost-effective items.

    Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the Smartphone Sensors industry to benefit clients and increase the market sector. In recent years, the Smartphone Sensors industry has offered manufacturers some of the most significant advantages. Major players in the Smartphone Sensors market, including MS AG (Austria), Broadcom Inc. (US), DYNA IMAGE Corporation (China), Murata Electronics Oy (Finland), NEXT Biometrics Group ASA (Norway), Omron Corporation (Japan), Samsung Electronics Co. Ltd. (South Korea), Sony Corporation (Japan)., and others, are attempting to increase market demand by investing in research and development operations.

    Samsung is dedicated to abiding by local laws and regulations and enforcing a strict code of conduct for all employees. Samsung adheres to a straightforward business tent: to usage its technology and expertise to develop top-notch goods and services that make a more cultured world. Samsung provides a high importance on its people and technologies to do this. For Instance: In January 2023, Samsung Electronics launched its new MICRO LED, Neo QLED, and Samsung OLED product lines, along with lifestyle products and accessories, before CES® 2023.

    Apple Inc. is a multinational American technology business with its main office in Cupertino, California. According to revenue, Apple will be the top technological business in the world in 2022, with US $ 394.3 billion in sales. According to market capitalization, Apple is the largest corporation in the world as of March 2023. For Instance: In September 2022, the iPhone 14 and iPhone 14 Plus, which come in two sizes, 6.1 and 6.7 inches and include a smart design, camera upgrades, and game-changing new safety measures, were introduced by Apple. The iPhone 14 and iPhone 14 Plus have a powerful camera system that incorporates the primary and front TrueDepth cameras, the Ultra Wide camera for uncommon perspectives, and the photonic engine, an enhanced picture pipeline.

    Key Companies in the Smartphone Sensors market include

    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)

    Industry Developments

    • September 2022: Comcast and Samsung Electronics announced their partnership to create 5G Radio Access Network (RAN) technologies to enhance 5G connection for Xfinity Mobile and Comcast Business Mobile users in Comcast service zones. Samsung will provide 5G RAN technology, and Comcast will deploy Citizens Broadband Radio Service (CBRS) and 600 MHz spectrum to provide 5G access to consumer and business users in the US.
    • October 2022: Huawei announced the release of the newest antenna solutions, including the Maxwell platform and the X2 antenna series, for the subsequent 5G antenna innovation stage. The new technologies speed up 5G deployment by improving antenna and setup capabilities.

    Market Segmentation

    Smartphone Type Outlook

    • Standard Smartphone
    • Rugged Smartphone
    • Smartwatches
    • Other Wearable

    Price Outlook

    • USD 300 to USD 500
    • USD 100 to USD 300
    • Above USD 500
    • Under USD 100

    Manufacturer Outlook

    • Apple Inc.
    • Samsung Electronics
    • Huawei Technology
    • Xiaomi Inc.
    • Oppo
    • Sony Corporation
    • HMD Global

    Application Outlook

    • High-Level
    • Mid-Level
    • Low-Level

    Manufacturer Outlook

    North America
    • US
    • Canada
    Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    Asia-Pacific
    • China
    • Japan
    • India
    • Italy
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    Rest of the World
    • Middle East
    • Africa
    • Latin America

    Report Scope

    Attribute/Metric Details
    Market Size 2023 USD 556.6 Billion
    Market Size 2024 USD 596.7 Billion
    Market Size 2032 USD 970.7 Billion
    Compound Annual Growth Rate (CAGR) 6.27% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2018- 2021
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Application, End-User, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The U.S., Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Illumina Inc., Precision Biologics, Danaher Corporation, GE Healthcare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., and Biogen
    Key Market Opportunities Technological advancements in diagnostics sector
    Key Market Dynamics The growing demand for novel drug discovery to combat the growing incidence of cancers and other diseases and numerous collaborations among researchers and market players

    Market Highlights

    Author

    Aarti Dhapte
    Team Lead - Research

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. DANAHER CORPORATION: SWOT ANALYSIS
    2. EXAGEN INC.: SWOT ANALYSIS

    Personalized Medicine Market Segmentation

    Personalized Medicine Product Outlook (USD Billion, 2018-2032)

    • Personalized Medicine Diagnostics
    • Personalized Medicine Therapeutics
    • Personalized Medical Care
    • Personalized Nutrition and Wellness

    Personalized Medicine Application Outlook (USD Billion, 2018-2032)

    • Oncology
    • CNS
    • Immunology
    • Respiratory
    • Others

    Personalized Medicine End-User Outlook (USD Billion, 2018-2032)

    • Hospitals
    • Diagnostic Centers
    • Research & Academic Institutes
    • Others

    Personalized Medicine Regional Outlook (USD Billion, 2018-2032)

    • North America Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • US Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Canada Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
    • Europe Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Germany Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • France Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • UK Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Italy Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Spain Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Rest Of Europe Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
    • Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • China Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Japan Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • India Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Australia Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
    • Rest of the World Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Middle East Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Africa Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others
      • Latin America Outlook (USD Billion, 2018-2032)

      • Personalized Medicine by Product
        • Personalized Medicine Diagnostics
        • Personalized Medicine Therapeutics
        • Personalized Medical Care
        • Personalized Nutrition and Wellness
      • Personalized Medicine by Application
        • Oncology
        • CNS
        • Immunology
        • Respiratory
        • Others
      • Personalized Medicine by End-User
        • Hospitals
        • Diagnostic Centers
        • Research & Academic Institutes
        • Others

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Jongwon Byun

    Director, Research Operations
    Case Study

    Smartphone Motherboard Parts Manufacturing Research